Skip to contentB
BIO-TECHNE Corp
B
TECHBIO-TECHNE Corp Q4 2020 · 10-K
Revenue$175.83M$175.83M−8.3% vs Q4 2019 Net Income$58.85M$58.85M+257.5% vs Q4 2019 EPS Diluted$1.48$1.48+252.4% vs Q4 2019 Gross Profitderived$113,314,000−11.7% The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BIO-TECHNE Corp · CIK 842023 · Engraved from SEC EDGAR
Operating Incomederived$39,309,000−9.1% Operating Cash Flowderived$44,791,000−19.9% Free Cash Flowderived$27,418,000−38.0% Margins · derivedGross margin64.4%−2.5 pt vs Q4 2019
Operating margin22.4%−0.2 pt vs Q4 2019
Net margin33.5%+24.9 pt vs Q4 2019
ended Jun 30, 2020 · filed Aug 26, 2020 · 57 d after period end